BioNTech SE (22UA) — Long-term Investment Intensity
BioNTech SE (22UA) has a Long-term Investment Intensity of 10.8% as of March 2026. Long-term investments of €2.28 Billion represent 10.8% of total assets of €21.07 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check BioNTech SE cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
BioNTech SE Long-term Investment Intensity (2016–2025)
This chart shows how BioNTech SE's Long-term Investment Intensity has evolved across 8 annual periods from 2016 to 2025. As of March 2026, the intensity stands at 10.8%, reflecting long-term investments of €2.28 Billion against total assets of €21.07 Billion EUR. Explore debt repayment capacity of BioNTech SE to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for BioNTech SE (2016–2025)
The table below presents the year-by-year Long-term Investment Intensity for BioNTech SE from 2016 to 2025, covering 8 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market cap of BioNTech SE.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 11.6% | €2.55 Billion | €21.99 Billion | ▲ +6.1 pp |
| 2024 | 5.6% | €1.25 Billion | €22.53 Billion | ▲ +0.5 pp |
| 2023 | 5.1% | €1.18 Billion | €23.01 Billion | ▲ +4.8 pp |
| 2022 | 0.3% | €80.20 Million | €23.28 Billion | ▲ +0.2 pp |
| 2021 | 0.1% | €21.30 Million | €15.83 Billion | ▲ +0.1 pp |
| 2018 | 0.0% | €18.00K | €652.99 Million | ▼ 0.0 pp |
| 2017 | 0.0% | €19.00K | €374.71 Million | ▼ 0.0 pp |
| 2016 | 0.0% | €66.00K | €389.96 Million | — |